HemoCue AB (part of Radiometer Group)

Founded over 40 years ago, HemoCue is a global leader in the field of diagnostics known as near-patient, or point-of-care testing (POCT). HemoCue offers POCT for hemoglobin, glucose and HbA1c as well as total and differential white blood cell count.

Since the beginning, our focus has been on accuracy in every detail. We offer lab-quality results at the point of care without sacrificing the accuracy and precision offered by a central clinical lab.

Healthcare providers around the world rely on the immediate results so they can make informed decisions when they need them the most. Today, four HemoCue tests are performed every second worldwide. Tests that are fast and easy to perform – by anyone. Because when it comes to caring for people, we refuse to compromise.

HemoCue is proud to be part of Danaher.

Danaher is a global science and technology leader. Together we combine our capabilities to accelerate the real-life impact of tomorrow’s science and technology to improve human he

For more information, visit our website: www.hemocue.com

This is the official HemoCue LinkedIn page which may contain information on products not released in all markets. For reference on products and services available in specific markets, please go to your local HemoCue website found on hemocue.com.

We welcome and encourage your comments and look forward to engaging with you. However, we do not endorse or approve user-generated content, content that promotes any other use of our products other than stated in the intended use, and will remove any comments or references to such off-label use as well as comments that are considered abusive or defamatory.

The collection, storage, use, disclosure, retention, and destruction of data on this page, including any personal data, are all subject as applicable, to LinkedIn's User Agreement and Privacy Policy and to HemoCue AB Data Privacy Policy, which can be found here: https://www.hemocue.com/en/about-us/legal/hemocue-online-privacy-policy